GenAI drug discovery firm Insilico raises $123m as it eyes Hong Kong IPO

GenAI drug discovery firm Insilico raises $123m as it eyes Hong Kong IPO

Photo by Braňo on Unsplash

16 June, 2025

Edited by: Pramod Mathew

Alex Zhavoronkov drug discovery Generative AI Hong Kong IPO Insilico Medicine Value Partners Group Warburg Pincus

Printed by Unregistered user on Fri, 03 Oct 2025 14:16:44 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

Sanofi, Cathay Capital set up $275m fund to back clinical-stage innovative drugs in China

VCs remain bullish on China’s deeptech despite LLM bubble bursting

Read more from Greater China

China’s outbound EV investments shift toward Asia, capital-light segments

Visa-free policy, US tariffs push Chinese companies to Malaysia